Cargando…

Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer

Alterations in the insulin-like growth factor (IGF)-system were evaluated in 16 patients treated with diethylstilboestrol 5 mg 3 times daily. Fasting blood samples were obtained before treatment and after 2 weeks, 1 month and/or 2–3 months on therapy. Insulin-like growth factor (IGF)-I, IGF-II, free...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helle, S I, Geisler, J, Anker, G B, Leirvaag, B, Holly, J M P, Lønning, P E
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364048/ https://www.ncbi.nlm.nih.gov/pubmed/11461068 http://dx.doi.org/10.1054/bjoc.2001.1871

Ejemplares similares

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer
por: Helle, S I, et al.
Publicado: (2001)

The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast.
por: Ribeiro, G. G.
Publicado: (1976)

Diethylstilboestrol Exposure Does Not Reduce Testosterone Production in Human Fetal Testis Xenografts
por: Mitchell, Rod T., et al.
Publicado: (2013)

Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines
por: Perks, C M, et al.
Publicado: (1999)

Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer
por: Omlin, A, et al.
Publicado: (2013)

Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy
por: Cox, R A, et al.
Publicado: (2008)

Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'
por: Shamash, J, et al.
Publicado: (2014)

Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'
por: Omlin, A, et al.
Publicado: (2014)

Alterations of the retinoblastoma gene in metastatic breast cancer
por: Berge, Elisabet Ognedal, et al.
Publicado: (2011)

Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men
por: Allen, N E, et al.
Publicado: (2000)

Insulin-like growth factor-I and prostate cancer: a meta-analysis
por: Shi, R, et al.
Publicado: (2001)

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
por: Knappskog, Stian, et al.
Publicado: (2012)

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models
por: Lee, O H, et al.
Publicado: (2000)

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy
por: Foulstone, EJ, et al.
Publicado: (2010)

Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization
por: Dennison, GJ, et al.
Publicado: (2008)

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
por: Renehan, A G, et al.
Publicado: (2000)

Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
por: Ireland, Lucy, et al.
Publicado: (2018)

Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
por: Clarke, K, et al.
Publicado: (2001)

Association between the serum insulin‐like growth factor‐1 concentration in the first trimester of pregnancy and postpartum depression
por: Adachi, Sho, et al.
Publicado: (2021)

Prevalence of the CHEK2 R95* germline mutation
por: Knappskog, Stian, et al.
Publicado: (2016)

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska, Hanna A, et al.
Publicado: (2015)

The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease
por: Pidgeon, G P, et al.
Publicado: (1999)

Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia
por: Trobec, Katja, et al.
Publicado: (2011)

Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
por: Austrup, F, et al.
Publicado: (2000)

Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation
por: Zee, J van der, et al.
Publicado: (1999)

Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.
por: Helle, S. I., et al.
Publicado: (1998)

Insulin-like growth factors: Ligands, binding proteins, and receptors
por: LeRoith, Derek, et al.
Publicado: (2021)

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
por: O'Byrne, K J, et al.
Publicado: (1999)

Investigation of female survival benefit in metastatic melanoma
por: Richardson, B, et al.
Publicado: (1999)

Preparatory training attenuates drastic response of the insulin-like growth factor binding protein 1 at the point of maximal oxygen consumption in handball players
por: Nedić, Olgica, et al.
Publicado: (2017)

Brain insulin resistance deteriorates cognition by altering the topological features of brain networks
por: Su, Fan, et al.
Publicado: (2016)

Chromosomal alterations in the clonal evolution to the metastatic stage ofquamous cell carcinomas of the lung
por: Petersen, S, et al.
Publicado: (2000)

Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation
por: Forbes, Karen, et al.
Publicado: (2015)

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
por: Parisot, J P, et al.
Publicado: (1999)

Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
por: Fujimoto, J, et al.
Publicado: (2001)

Birthweight, childhood growth and risk of breast cancer in a British cohort
por: Stavola, B L De, et al.
Publicado: (2000)

Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine
por: Daikuhara, Seiichi, et al.
Publicado: (2015)

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type
por: Vos, C B J, et al.
Publicado: (1999)

Breast milk nutrient content and infancy growth
por: Prentice, Philippa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_he3lnkn70q3fsuidh0ejrd9q6s